Back to Top Skip to main content

Understanding the potential of COVID-19 convalescent plasma

Researcher scans a unit of plasma in lab. U.S. Army Sgt. Reginald Miles labels donated liquid plasma at the Landstuhl Blood Donor Center. Researchers are studying COVID-19 convalescent plasma to harness the power of neutralizing antibodies to help patients. (Photo by Volker Ramspott)

Recommended Content:

Coronavirus | Convalescent Plasma Collection Program | Armed Services Blood Program

The Department of Defense has set a goal to collect more than 8,000 donated units of plasma from patients who have recovered from COVID-19 by Sept. 30, 2020. This blood will be used to treat critically ill patients and support the development of an effective treatment against the disease.

Like a missile locking on its target, antibodies attack invaders inside the body with a singularity of purpose: search and destroy. Typically, infection-fighting white blood cells produce antibodies as an appropriate response to an invading germ. In some people whose immune systems can’t mount a sufficient attack against a virus, donated antibodies from another person’s plasma may help. Researchers believe the power of antibodies lies in their ability to bind to a virus and neutralize it, or block it from entering cells, said Dr. Kayvon Modjarrad, director of the Emerging Infectious Diseases Branch at the Walter Reed Army Institute of Research in Silver Spring, Maryland. Modjarrad leads the Army’s COVID-19 vaccine development research.

But not all antibodies are created the same. “Antibodies come in different flavors, some of them are neutralizing and some of them are non-neutralizing and we don’t know exactly which individuals are developing what type of antibody,” said Shelly Krebs, chief of B Cell Biology Core at WRAIR Military HIV Research program.

COVID-19 convalescent plasma, or CCP, from a recovered patient could be a mixture of both neutralizing and non-neutralizing antibodies. In fact, people infected with COVID-19 can have varying antibody responses. Some may not have enough antibodies in their plasma to benefit another patient, which is why CCP first needs to be tested for neutralizing antibody levels before transfusing, explained Modjarrad. His lab works to understand the mechanism of COVID-19 antibodies to predict the levels required to offer a person protection from the virus.

Transfusing antibodies provides short-term immunity as the donor antibodies last several weeks to months inside the body, said Navy Capt. (Dr.) Todd Gleeson of the Navy Bloodborne Infection Management Center, located at Naval Support Activity Bethesda, Maryland. “It is likely that a person with COVID-19 who receives CCP will also still develop their own immune cells and produce antibodies to fight the virus if that person is re-exposed in the future,” said Gleeson, who leads a convalescent plasma study of patients at Walter Reed National Military Medical Center also at NSAB in Bethesda. But scientists just can’t confirm that yet. They hope to uncover the answer and many more as they study CCP and COVID-19 antibodies to better treat patients and develop future vaccines.

Military medical treatment facilities will soon take part in an observational study across the Department of Defense to help researchers track trends among patients with COVID-19. The data will help trace recovered patients to ask for CCP donations as the DoD seeks to build a storehouse of CCP for patients admitted to Military Health System facilities and those deployed outside the U.S., explained Army Col. (Dr.) Andrew Cap, director of research at the Army Institute of Surgical Research in San Antonio, Texas. “The goal is to build a convalescent plasma capability within the DoD, both on the collection and on the treatment side,” said Cap, who helped draft a CCP protocol for the DoD.

Future research may lead to the development of highly concentrated neutralizing antibodies extracted from large quantities of convalescent plasma as a potential therapy for prevention and treatment, added Cap.

Scientists believe monoclonal antibodies—derived from a single immune cell—may also hold potential as both a treatment and preventive measure against COVID-19. Krebs and her team have engineered monoclonal antibodies in the lab by isolating the best neutralizing antibodies from CCP samples to create an army of exact replicas that target the COVID-19 virus down to the atomic level, explained Modjarrad. “We know where and how well it’s going to target, and we know the kinetics of how long it will last in the body and how long it will provide protection,” he explained, noting convalescent plasma does not provide that level of effectiveness. “CCP is not generally used for prevention but for treatment.” Monoclonal antibodies could be used for both treatment and prevention of COVID-19 because the transfused neutralizing antibodies would provide immediate immunity, he added.

Monoclonal antibodies have been in use for decades and revolutionized cancer treatment. Krebs’ lab plans to expand the research into monoclonal antibodies against COVID-19 into animal studies this summer. “Our primary goal is to come up with a treatment for people who have COVID-19,” she said.

Anyone able to donate convalescent plasma should contact the Armed Services Blood Program or go online to find a complete list of available collection centers.

You also may be interested in...

DHA contributes to COVID-19 vaccine effort

Article
12/16/2020
Vaccine bottles

While Pfizer’s vaccine is being distributed to all U.S. jurisdictions for administration, several more candidates are in development and clinical trials continue to be conducted simultaneously with pharmaceutical partners.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Toolkit | COVID-19 Vaccine Toolkit

COVID-19 Vaccine Headed to NMC San Diego and NH Camp Pendleton

Article
12/15/2020
Gloved hands preparing vaccine for transportation

[T]he first doses of the vaccine will be given to frontline health care workers and first responders, including emergency medical services personnel, security forces, and other essential personnel.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

Frontline health care workers among first in DOD for COVID-19 vaccine

Article
12/15/2020
Man getting vaccine

"This is a very important day, not just for the Department of Defense, but for our nation," Miller said before getting his vaccination.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

COVID-19 Convalescent plasma collection continues

Article
12/14/2020
Three units of CCP laying on a table

CCP has a one-year shelf life, so collected units will begin to expire in 2021.

Recommended Content:

Coronavirus | Convalescent Plasma Collection Program | Armed Services Blood Program

National Guard and Reservists doing their part to fight COVID-19

Article
12/14/2020
Military personnel performing nasal swabs of people in a row of cars

“We can do a thousand tests in just a couple hours,” Keller said. It was an example of ingenuity taking place all over the country, with members of the Military Health System partnering with civilian hospitals and clinics.

Recommended Content:

Coronavirus

Hepburn: DOD role in Operation Warp Speed was ‘transformative’

Article
12/11/2020
Medical technician getting a syringe ready to give a vaccine

The FDA announced on Dec. 8 that its review of the Pfizer vaccine found it to be safe and efficacious.

Recommended Content:

COVID-19 Vaccine Efforts | Vaccine Trials | Coronavirus

DOD Officials Announce Distribution Plan for Initial COVID-19 Vaccine

Article
12/10/2020
Image of Mr. McCaffery speaking at a podium at the Pentagon

DOD is expected to receive around 44,000 doses of the Pfizer vaccine in the initial phase.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

Deputy defense secretary stresses team approach in battling COVID

Article
12/10/2020
Soldier wearing mask, standing at computer monitors in an office building

The Military Health System has played an important role implementing the National Defense Strategy, Norquist said.

Recommended Content:

MHS Transformation | Coronavirus | COVID-19 Vaccine Efforts | Health Readiness | COVID-19 Vaccine Toolkit

MHS leaders discuss future of military medicine during AMSUS panel

Article
12/9/2020
Military personnel, wearing masks, standing in a line in front of flags

For Dingle, readiness is the key issue during the transition.

Recommended Content:

Coronavirus | Convalescent Plasma Collection Program | MHS Transformation

DOD Announces COVID-19 Vaccine Distribution Plan

Article
12/9/2020
Soldier wearing mask, sitting in front of computer monitors

The Department prioritizes DOD personnel to receive the vaccine based on CDC guidance.

Recommended Content:

Public Health | Coronavirus | COVID-19 Vaccine Efforts | Getting the COVID-19 Vaccine | COVID-19 Vaccine Toolkit

Malmstrom AFB airmen battle COVID-19, execute the mission

Article
12/8/2020
Soldier wearing protective gear leaning into a car to chat with other soldier

"The whole point of public health is to prevent any type of spread."

Recommended Content:

Coronavirus

Pandemic underscores MHS’ need for reform, McCaffery tells AMSUS

Article
12/8/2020
Army soldier gets nose swab

Before the COVID-19 pandemic, the MHS had embarked on reforms and initiatives to improve its medical support to the armed services.

Recommended Content:

MHS Transformation | Coronavirus | COVID-19 Vaccine Efforts | Vaccine Trials | Getting the COVID-19 Vaccine | COVID-19 Vaccine Toolkit

DOD continues to increase COVID-19 test capacity

Article
12/7/2020
Technician wearing gloves putting a sample into a container

In March as the first wave of the pandemic spread, there were only 15 testing sites able to perform 1,000 tests per week.

Recommended Content:

Coronavirus

Military medicine confronts an invisible enemy

Article
12/4/2020
Medical personnel set up in an outside military tent

The collective response to the pandemic underscored the MHS reputation for innovation, with practical applications beyond military medicine.

Recommended Content:

Combat Support | Warrior Care | Public Health | Coronavirus | Heroes Behind the Mask | December Toolkit

DOD experts provide COVID-19 update at Pentagon

Article
11/30/2020
Image of Dr. Payne

The Pentagon will be transitioning to Health Condition Bravo-Plus.

Recommended Content:

Coronavirus
<< < ... 6 7 8 9 10  ... > >> 
Showing results 76 - 90 Page 6 of 22

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.